Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2008
11/26/2008EP1993523A2 Compositions and methods for treatment of disorders of protein aggregation
11/26/2008EP1993522A2 Resveratrol and/or grape leaf extract as i.a. endurance improver, anti-aging agent, muscle strength improver
11/26/2008EP1993521A1 Compositions comprising apocynin , ginkgo and ginger and uses thereo
11/26/2008EP1993519A2 Methods and compositions for deterring abuse of orally administered pharmaceutical products
11/26/2008EP1993518A2 Dosage forms for administering combinations of drugs
11/26/2008EP1993517A2 Modified release formulations and methods of treating inflammatory bowel disease
11/26/2008EP1993383A2 Composition used as a nutritional supplement and medication for the treatment of degenerative visual disorders and inflammation
11/26/2008EP1993382A2 All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization
11/26/2008EP1993360A2 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
11/26/2008EP1922420A4 METHOD AND SUBSTANCES FOR ISOLATING miRNAs
11/26/2008EP1811957B1 Solid pharmaceutical composition comprising donepezil hydrochloride
11/26/2008EP1802566B1 Hexafluoroisopropanol substituted ether derivatives
11/26/2008EP1800134B1 Method for diagnosing and treating crohn's disease
11/26/2008EP1763528B1 Pyrazolopyridine derivatives
11/26/2008EP1756084B1 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
11/26/2008EP1740568B1 Benzofuran and benzothiophene derivatives useful for the treatment of cardiovascular disease.
11/26/2008EP1706122B1 Anti-viral pharmaceutical compositions
11/26/2008EP1673388B1 Cxcl8 antagonists
11/26/2008EP1603877B1 NOVEL AMINOPYRIDINE DERIVATIVES AS mGIuR5 ANTAGONISTS
11/26/2008EP1594492B1 Novel inhibitors of formation of advanced glycation endproducts (ages)
11/26/2008EP1578428A4 Treating alcohol and or substance abuse by antagonizing alpha a2 drenergic receptors with weak dopamine blocking
11/26/2008EP1534707B9 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
11/26/2008EP1534246B1 Sustained release pharmaceutical composition of a cephalosporin antibiotic
11/26/2008EP1523239B1 Use of a composition and a cleaning tablet containing said composition for disinfecting purposes
11/26/2008EP1515736B1 Compositions against inflammatory processes
11/26/2008EP1506162B1 Synthesis of benzonitriles and benzimidates
11/26/2008EP1496914B1 (20S)-1alpha-HYDROXY-2alpha-METHYL AND 2beta-METHYL-19-NOR-VITAMIN D3 AND THEIR USES
11/26/2008EP1480642B1 Peroxisome proliferator activated receptor modulators
11/26/2008EP1480595B1 Use of esters of long-chain fatty acids for treatment of autoimmune diseases
11/26/2008EP1473300B1 Pharmaceutical composition for the treatment of psoriasis and other skin diseases
11/26/2008EP1438296B1 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
11/26/2008EP1421070B1 New piperidinyl derivates as modulators of chemokine receptor activity
11/26/2008EP1419173B1 Peptides that bind to atherosclerotic lesions
11/26/2008EP1414455B1 Isoquinoline inhibitors of p38
11/26/2008EP1392258B1 Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
11/26/2008EP1381382B1 Methods and compositions for the treatment of diseases of the eye
11/26/2008EP1370228B1 Systems for delivering a cosmetic and/or therapeutic active to oral surfaces
11/26/2008EP1365763B1 Farnesyl protein transferase inhibitor combinations with antiestrogen agents
11/26/2008EP1337517B1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
11/26/2008EP1330452B1 Pyrazine derivatives as modulators of tyrosine kinases
11/26/2008EP1328267B1 Method of treating cancer using dithiocarbamate derivatives
11/26/2008EP1299110B1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and antimetabolites
11/26/2008EP1264548B1 Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy
11/26/2008EP1257642B1 Partners of ptb1 domain of fe65, preparation and uses
11/26/2008EP1234574B1 Hair growth stimulant
11/26/2008EP1155015B1 Process for the production of tert-butyl (e)-(6-¬2-¬4-(4-fluorophenyl)-6-isopropyl-2-¬methyl(methylsulfonyl)amino pyrimidin-5-yl vinyl (4r,6s)-2,2-dimethyl¬1,3 dioxan-4-yl)acetate
11/26/2008EP1124953B1 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
11/26/2008EP0865293B1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling
11/26/2008CN101313066A Modulation of glucocorticoid receptor expression
11/26/2008CN101312979A Pyrimidine compounds for the treatment of inflammatory disorders
11/26/2008CN101312978A 2-heteroaryl-pyrazolo-[4, 3-e]-1, 2, 4-triazolo-[1,5-c]-pyrimidine as adenosine a2a receptor antagonists
11/26/2008CN101312977A Fused heterocyclic compounds useful as kinase modulators
11/26/2008CN101312976A Spirocyclic compounds as hdac inhibitors
11/26/2008CN101312974A Pyrazoloisoquinoline derivatives
11/26/2008CN101312973A Novel indolizine derivatives, method for preparing same and therapeutic compositions comprising same
11/26/2008CN101312972A Bicyclic cinnamide compound
11/26/2008CN101312971A Substituted bicyclic pyrimidone derivatives
11/26/2008CN101312970A 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
11/26/2008CN101312969A Azaindole-2-carboxamide derivatives
11/26/2008CN101312968A Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
11/26/2008CN101312967A Carbamate compounds as 5-ht4 receptor agonists
11/26/2008CN101312966A Benzothiazole cyclobutyl amine derivatives and their use as histamine-3 receptors ligands
11/26/2008CN101312965A Morpholine type cinnamide compound
11/26/2008CN101312964A 4-oxadiazolyl-piperidine compounds and use thereof
11/26/2008CN101312963A Glucagon receptor antagonists, preparation and therapeutic uses
11/26/2008CN101312962A Therapeutic agent for cornea/conjunctive disorder
11/26/2008CN101312961A Isoquinoline and benzo[H]isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of the histamine h3 receptor
11/26/2008CN101312960A F,G,H,I and K crystal forms of imatinib mesylate
11/26/2008CN101312959A Novel thiophene derivatives
11/26/2008CN101312958A 3, 6-dihydro-2-oxo-6H-(1,3,4)thiadiazine derivatives
11/26/2008CN101312957A 1,2,5-thiazolidine derivatives useful for treating conditions mediated by protein tyrosine phosphatases (ptpase)
11/26/2008CN101312956A Substituted 5-phenyl-3,6-dihydro-2-oxo-6H-[1,3,4]thiadiazines
11/26/2008CN101312954A 4-aminopyrimidine-5-thione-derivatives for the treatment of cancer
11/26/2008CN101312953A Pharmacologically active compounds containing sulfur
11/26/2008CN101312952A Tetrahydro-cyclopentyl pyrazole cannabinoid modulators
11/26/2008CN101312951A Heterocyclic compound possessing ó± type 11 beta-hydroxy steroid dehydrogenase inhibiting activity
11/26/2008CN101312950A Alkyl sulfoxide quinolines as nk-3 receptor ligands
11/26/2008CN101312949A Process for synthesizing remifentanil
11/26/2008CN101312946A 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
11/26/2008CN101312940A Glucagon receptor antagonists, preparation and therapeutic uses
11/26/2008CN101312766A Treatment of sub-gingival pocket infections
11/26/2008CN101312746A Preparation containing iron(iii)-complexes and redox substances
11/26/2008CN101312741A Chemo-immunotherapy method
11/26/2008CN101312738A Morinda citrifolia based antifungal formulations and methods
11/26/2008CN101312735A Combination of polychitosamine and fibrate for the prevention and treatment of hyperlipidemia
11/26/2008CN101312734A A therapeutic composition containing an organosilane quaternary compound and hydrogen peroxide for treating skin disorders
11/26/2008CN101312733A Use of estradiol valerate or estradiol combined with dienogest for the oral therapy of dysfunctional uterine bleeding in the form of oral contraceptives
11/26/2008CN101312732A Method of preventing oral staining
11/26/2008CN101312731A Adenosine a2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders
11/26/2008CN101312730A Pharmaceutical compositions comprising buprenorphine
11/26/2008CN101312729A Treatment of asthma and copd using triple-combination therapy
11/26/2008CN101312728A Pharmaceutical composition for improvement of cognitive function
11/26/2008CN101312727A Anti-worm formulation
11/26/2008CN101312726A Hexahydro cyclooctyl pyrazole cannabinoid modulators
11/26/2008CN101312725A Hexahydro cyclooctyl pyrazole cannabinoid modulators
11/26/2008CN101312724A Tetrahydro-indazolyl cannabinoid modulators
11/26/2008CN101312723A Glucagon receptor antagonists, preparation and therapeutic uses
11/26/2008CN101312722A Modulators of atp-binding cassette transporters
11/26/2008CN101312721A Organic compounds comprising a glycopyrronium salt
11/26/2008CN101312720A 2-氨基苯甲酰胺衍生物 2-amino-benzamide derivative
1 ... 2980 2981 2982 2983 2984 2985 2986 2987 2988 2989 2990 2991 2992 2993 2994 2995 2996 2997 2998 2999 3000 ... 7860